HERON THERAPEUTICS, INC. /DE/ (HRTX) Revenue 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$154.9MFY2025 · since FY2016: $1.3M → $154.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $154.9M | +7.4% |
| FY2024 | $144.3M | +13.6% |
| FY2023 | $127.0M | +18.0% |
| FY2022 | $107.7M | +24.7% |
| FY2021 | $86.3M | -2.6% |
| FY2020 | $88.6M | -39.3% |
| FY2019 | $146.0M | +88.4% |
| FY2018 | $77.5M | +151.8% |
| FY2017 | $30.8M | +2305.6% |
| FY2016 | $1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice